First COVID-19 The vaccine tested in the U.S. boosted people’s immune systems just as scientists expected, researchers reported Tuesday. The shots are set to begin the key final test. “No matter how this is cut, this is good news” Dr. Anthony Fauci, the U.S. government’s leading infectious disease expert, told …
Read More »
CHICAGO (Reuters) – Moderna Inc’s (MRNA.O) The experimental vaccine for COVID-19 was shown to be safe and elicited immune responses in all 45 healthy volunteers in an early-stage study, US researchers reported Tuesday. FILE PHOTO: A sign marks the headquarters of Moderna Inc, which is developing a coronavirus vaccine, in …
Read More »
The Nasdaq announced Monday that Moderna will be added to its Nasdaq 100 index in July. Moderna’s shares rose as much as 18% on Monday. On Monday, Jefferies kicked off Moderna’s coverage with a “buy” rating and a target price of $ 90 over the approval potential of the pharmaceutical …
Read More »
Text size Maddie Meyer / Getty Images Moderna’s shares have risen 239% so far this year, and the biotech company, which has no approved medications, has a market capitalization of more than $ 24 billion. But in a note sent out Monday morning, Jefferies analyst Michael Yee writes that the …
Read More »
Modern (MRNA) – Get report it increased after Jefferies analyst Michael Yee began coverage of the biopharmaceutical company with a buy rating and a stock price target of $ 90, and Nasdaq said it would add the shares to the Nasdaq 100. The company’s coronavirus vaccine candidate could sell for …
Read More »